Tarceva, Kepivance, And Macugen Approvals Are Quiet Milestones For FDA

Genentech/OSI's Tarceva, Amgen's Kepivance and Pfizer/Eyetech's Macugen are the first three products approved under the "continuous marketing application" pilot program